A tool used to analyze cancerous tumors based on algorithms built to map distant galaxies is getting a major influx of funding.
Why it matters: The imaging platform — called AstroPath — is able to pinpoint how certain tumor cells interact with the body's tissues, allowing doctors to potentially learn more about who might respond well to various treatments.